Wang Jihong, Yuan Yueling, Su Chanjuan, Bao Yan, Xu Weide, Yao Yandan, Liang Lifang, Zeng Yuxuan, Xiong Menghua
School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, China.
National Engineering Research Centre for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, China.
J Am Chem Soc. 2025 Jan 8;147(1):1008-1016. doi: 10.1021/jacs.4c14199. Epub 2024 Dec 28.
Oncolytic therapy, inducing cell death via cell membrane lysis, holds considerable promise in cancer treatment. However, achieving precise control over the structure and function of oncolytic materials for highly selective oncolytic therapy is a key challenge in the context of the subtle differences between tumor and normal tissues/cells. Herein, we report the development of pH-ultrasensitive oncolytic polyesters (pOPs) with an alternating sequence of ionizable and hydrophobic groups. This design enables a refined "OFF" to "ON" switch within 0.2 pH units, ensuring high selectivity in membranolytic activity and cytotoxicity of pOPs between the pH levels of normal tissues and tumor acidity. The top-performing pOP, P(P-AC7), demonstrated a maximum tolerated dose of >100 mg kg after intravenous administration and potent cytotoxicity at pH 6.8. Notably, the molecular weight of P(P-AC7) had a minimal effect on its pH-dependent cytotoxicity once the degree of polymerization was ≥49, ensuring consistency in properties across batches. P(P-AC7) exerts membranolytic activity by interacting with phosphatidylserine at pH 6.8 and shows high antitumor efficacy in various tumor models. Overall, we developed a strategy to develop oncolytic polymers with a precise structure for selective oncolytic therapy.
溶瘤疗法通过细胞膜裂解诱导细胞死亡,在癌症治疗中具有巨大潜力。然而,鉴于肿瘤组织与正常组织/细胞之间存在细微差异,要实现对溶瘤材料的结构和功能进行精确控制以实现高度选择性的溶瘤治疗,是一项关键挑战。在此,我们报告了一种具有可电离基团和疏水基团交替序列的pH超敏感溶瘤聚酯(pOPs)的研发情况。这种设计能够在0.2个pH单位内实现精确的“关闭”到“开启”转换,确保pOPs在正常组织pH水平和肿瘤酸度之间的膜溶解活性和细胞毒性具有高选择性。性能最佳的pOP,即P(P-AC7),静脉注射后的最大耐受剂量>100 mg/kg,且在pH 6.8时具有强大的细胞毒性。值得注意的是,一旦聚合度≥49,P(P-AC7)的分子量对其pH依赖性细胞毒性的影响极小,确保了不同批次产品性质的一致性。P(P-AC7)在pH 6.8时通过与磷脂酰丝氨酸相互作用发挥膜溶解活性,并在各种肿瘤模型中显示出高抗肿瘤疗效。总体而言,我们开发了一种策略来制备具有精确结构的溶瘤聚合物用于选择性溶瘤治疗。